M. Harigai et al., Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus, LUPUS, 8(3), 1999, pp. 227-233
Objective: To investigate the immunopathological significance of CD40/CD40
ligand system for B cell hyperactivation in SLE patients, the expression an
d the function of CD40 on B cells were compared with those of normal contro
ls.
Methods: Expression of CD40 was evaluated by flow cytometry. DNA synthesis
of B cells were measured by H-3 - TdR incorporation. Antibody production wa
s assessed by ELISA.
Results: There was no significant difference between SLE and normal control
s in CD40 expression on peripheral blood B cells. Recombinant CD40 ligand-l
eucine zipper fusion protein (CD40L-LZ) significantly enhanced 3H - TdR inc
orporation by both SLE and normal B cells (P < 0.01). H-3 - TdR incorporati
on of SLE B cells without stimuli (P < 0.001) and with CD40L-LZ stimulation
(P < 0.05) were significantly lower in SLE patients compared with normal c
ontrols. Active SLE B cells spontaneously produced significantly larger amo
unts of total IgG than normal B cells (P < 0.05). CD40L-LZ significantly in
creased the production of total IgG by SLE B cells (P < 0.05), but not by n
ormal B cells. Active SLE B cells spontaneously produced IgG anti-dsDNA and
ISG anti-ssDNA antibodies. CD40L-LZ significantly increased the production
of these autoantibodies by SLE B cells (P < 0.05). B cells from normal con
trols do not produce these autoantibodies spontaneously nor in response to
CD40L-LZ.
Conclusion: These findings indicate that signalling via CD40 plays an impor
tant role in B cell proliferation and autoantibody production in human SLE.